Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.00
Bid: 155.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.452%)
Open: 160.00
High: 160.00
Low: 160.00
Prev. Close: 160.00
TIDE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

mpro5 healthcare update

5 Jul 2018 08:38

RNS Number : 7090T
Crimson Tide PLC
05 July 2018
 

Crimson Tide plc ("Crimson Tide" or the "Company")

Continued investment in mpro5 for healthcare sees GCloud accreditation contract awards.

 

Crimson Tide is pleased to announce it has continued to add subscribers in the healthcare sector from its investments in R&D and marketing. Critical to our growth in the UK healthcare sector and specifically the public bodies responsible for delivery, it is also with great pleasure that the Company announces that mpro5 has been accepted to GCloud 10, the government marketplace for applications.

A global healthcare organisation has completed a second successful pilot of mpro5 for the identification and reporting of falsified and fraudulent medication. These pilots have been carried out in emerging nations where the effectiveness of contraceptives and anti-malarial medicines are critical to the economic and social development of the country as a whole. mpro5 has positively detected multiple instances of falsified medicine in the pilot areas. The Company is hopeful that further collaboration could lead to full rollouts in the pilot countries and other uses of mpro5 are under discussion.

Crimson Tide is in the process of adding a new biometric time and attendance module to mpro5 for a NHS trust in the North West of England, leveraging scanning capabilities to guarantee correct identification of individuals arriving on site.

The Company has also won a contract to aid AVM Services, which operates within Cambridge University Hospitals NHS Foundation Trust, with decontamination activities which are conducted in accordance with standardised UK regulatory procedures. mpro5 allows the scheduling of regular tasks in respect of porous loads and instruments including sterilizers, disinfectors and endoscopes. The commissioning of decontamination equipment is achieved through an mpro5 workflow that automatically awards the relevant compliance or commissioning document based on a complex scoring method.

A variety of our existing facilities management clients have continued the rollout of 49 point NHS cleaning compliance checks adding an increasing number of healthcare facilities to the locations where mpro5 is in daily use.

Crimson Tide's Executive Chairman, Barrie Whipp commented. "It is pleasing to hear of the NHS commitment to mobile applications for patients. mpro5 is a tactical solution to healthcare scenarios for not only patients, but clinicians and organisations that participate in the healthcare supply chain. We are now GCloud approved allowing us to push on with our investments and bring real change to processes in the state and private sector, locally and internationally"

‐ ends ‐

 For further information:

Crimson Tide plc Barrie Whipp / Luke Jeffrey / Steve Goodwin 01892 542 444

Arden Partners plc (Nomad/Broker) Steve Douglas / Dan Gee-Summons 020 7614 5900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAXXSEDKPEEF
Date   Source Headline
17th Apr 202410:05 amRNSBoard Changes
17th Apr 20247:00 amRNSPreliminary Results to 31 December 2023
23rd Jan 20247:00 amRNSTrading Update
28th Nov 20237:00 amRNSTrading Update
31st Oct 202311:45 amRNSResult of GM, Share Consolidation & TVR
10th Oct 20237:00 amRNSContract increases and extensions
6th Oct 20237:00 amRNSFurther re: Proposed Share Consolidation
5th Oct 20237:00 amRNSProposed Share Consolidation
26th Sep 20237:00 amRNSDirector dealing
25th Sep 20237:00 amRNSInterim Results
20th Sep 20237:00 amRNSContract Win
14th Sep 20237:00 amRNSStrengthened Operating Board
20th Jun 20234:20 pmRNSResult of AGM and Statement
31st May 20237:00 amRNSBoard changes
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20232:10 pmRNSDirectorate Change
4th May 20237:00 amRNSContract Win and Renewals
12th Apr 20237:00 amRNSPreliminary Results
5th Apr 20237:00 amRNSContract Win
1st Mar 20237:00 amRNSNotice of Results and Investor Presentation
7th Feb 20232:00 pmRNSHolding(s) in Company
6th Feb 20233:55 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSContract Win
18th Jan 20237:00 amRNSTrading Update
4th Jan 20235:00 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSDirector dealing
17th Nov 20227:00 amRNSSignificant contract expansion and extension
27th Sep 20227:00 amRNSInterim Results
25th Aug 20227:00 amRNSDirector Dealing
3rd Aug 20227:00 amRNSChange of Auditor
2nd Aug 20227:00 amRNSBoard Changes
25th Jul 20227:00 amRNSContract Win
19th Jul 20227:00 amRNSMultiyear contract win with major wholesaler
30th Jun 202211:27 amRNSResults of AGM & Statement
16th Jun 20224:30 pmRNSAnnual Report and Notice of AGM
7th Apr 20227:00 amRNSPreliminary Results
10th Feb 20227:00 amRNSContract Win and Strategic Partnership
3rd Feb 20227:00 amRNSTrading Update
7th Dec 20217:00 amRNSMaster Service Agreement with Compass Group
12th Nov 20217:00 amRNSDirectorate Change
11th Oct 202110:59 amRNSPDMR Dealing
28th Sep 20217:00 amRNSInterim Results
29th Jun 20213:08 pmRNSResult of AGM
16th Jun 20217:00 amRNSNorth America Appointment
4th Jun 20217:00 amRNSAnnual Report and Notice of AGM
4th May 20212:22 pmRNSTotal Voting Rights
28th Apr 202110:34 amRNSHolding(s) in Company
27th Apr 20217:00 amRNSHolding(s) in Company
26th Apr 20217:00 amRNSHolding(s) in Company
23rd Apr 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.